Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
Andrea Angeletti,
Gianluca Caridi,
Xhuliana Kajana,
Carolina Bigatti,
Agnese Spennacchio,
Decimo Silvio Chiarenza,
Gabriele Mortari,
Paolo Cravedi,
Enrico E. Verrina
Affiliations
Andrea Angeletti
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Correspondence: Andrea Angeletti, Nephrology, Dialysis and Transplantation; IRCCS Istituto Giannina Gaslini, Via Gaslini 5, 16147 Genova GE, Italy.
Gianluca Caridi
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Xhuliana Kajana
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Carolina Bigatti
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Agnese Spennacchio
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Decimo Silvio Chiarenza
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Gabriele Mortari
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
Paolo Cravedi
Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Enrico E. Verrina
Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
